BMNDF (Biomind Labs) Common Stock: $11.45 Mil (As of Mar. 2026)


What is Biomind Labs Common Stock?

Biomind Labs BMNDF Common Stock is $11.45 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Biomind Labs's quarterly common stock stayed the same from Sep. 2025 ($11.45 Mil) to Dec. 2025 ($11.45 Mil) and stayed the same from Dec. 2025 ($11.45 Mil) to Mar. 2026 ($11.45 Mil).

Biomind Labs's annual common stock increased from Dec. 2023 ($11.10 Mil) to Dec. 2024 ($11.45 Mil) but then stayed the same from Dec. 2024 ($11.45 Mil) to Dec. 2025 ($11.45 Mil).

Biomind Labs Common Stock Historical Data

* Premium members only.

The historical data trend for Biomind Labs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomind Labs Common Stock Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
11.10 11.10 11.10 11.45 11.45

Biomind Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.45 11.45 11.45 11.45 11.45

Biomind Labs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $11.45 Mil mean?
Biomind Labs (BMNDF) has a Common Stock of $11.45 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biomind Labs and its competitors.
Is Biomind Labs' Common Stock too high?
Biomind Labs' current Common Stock is $11.45 Mil.
How does Biomind Labs' Common Stock compare to VRTX and REGN?
Biomind Labs' Common Stock of $11.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biomind Labs and its competitors. Biomind Labs's current Common Stock is $11.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomind Labs stock overvalued right now?
Biomind Labs (BMNDF) has a current Common Stock of $11.45 Mil. The current Common Stock is $11.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Biomind Labs (BMNDF), the current Common Stock is $11.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomind Labs Business Description

Other Exchanges BMND:Canada
Address 701 West Georgia Street, Suite 515, Vancouver, BC, CAN, V7Y 1C6
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.